What's breaking now, across thousands of outlets.
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
NEW YORK: The world economy faces risks from stubborn inflation, higher debt service costs and investment in artificial intelligence (AI), although it has proven more resilient than many feared…
KUALA LUMPUR: Apex Securities Bhd expects Bank Negara Malaysia to keep the overnight policy rate (OPR) on hold at 2.75 per cent at its upcoming Monetary Policy Committee (MPC) meeting in November.
Diplomatic overtures between the US and Iran spark optimism in oil markets, despite ongoing Houthi attacks on Saudi Arabia, contributing to a notable drop in crude prices.
Financial technology company BDX Markets deployed a hybrid trading infrastructure platform incorporating distributed ledger technology across Asia to strengthen transaction verification for market…
"Bloomberg: The Asia Trade" brings you everything you need to know to get ahead as the trading day begins in Asia. Bloomberg TV is live from Sydney with Haidi Stroud-Watts and Paul Allen, getting…
Singapore's efforts to establish itself as a major gold hub are gathering pace, with DBS Group Holdings, the largest lender in Southeast Asia, expanding its bullion storage capacity as other banks…
